there’s a b2b company on here that basically uses hooters tactics as guerrilla marketing.
it’s so loud, sexualized, & relentlessly in your face that even if i needed exactly what they were selling i’d probably hesitate to buy from them.
which is kind of ironic cuz the marketing is incredibly effective at getting attention while simultaneously making the product feel less trustworthy overall.
Ken Lin retweeted
What happens when we believe in the power of small?
Hear from a KiwiCo kid with the curiosity and creativity to find out...
m.kiwico.com/AboutUs
Hey, I know this person!
We just did an internal session where everyone at @OMERSVentures shared their most inspirational business leaders. It was so cool to see so many votes for @sandraohlin.
Her story here: inc.com/christine-lagorio-ch…
Ken Lin retweeted
We challenged kids to build marble runs at home with the goal of connecting our community around the world one marble run at a time. In just a month, we received 700+ marble runs from 20+ countries. And now, we’re ready to reveal the full Mega Marble Run! kiwico.com/blog/2020/12/28/t…
Ken Lin retweeted
Last week, our Founder and CEO @SandraOhLin was featured on @HowIBuiltThis with @GuyRaz. They talk resilience during the pandemic and how KiwiCo has provided many families with resources and activities to promote learning at home. Listen here! #KiwiCo overcast.fm/+YsrY-NPxs
Congratulations, Andy!
We’re thrilled to learn that our co-founder Andrew Kruse has been promoted by Harvard to full professor with tenure, after only six years at the medical school. Andy is an expert on synthetic #antibodies and helped develop IPI’s antibody discovery platform. Congrats!
Ken Lin retweeted
This is why we need aggressive adoption of protective measures ASAP. Please RT #COVIDー19
Yooooooooo! Congrats @JasonLettmann!!
Roche to acquire Promedior for $390M upfront + $1B milestone
prnewswire.com/news-releases…
Recombinant human Pentraxin-2 for IPF and MF
Ken Lin retweeted
Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in clinical trials. Also, we accidentally found the first-ever inhibitor of the cyclin-dependent kinase CDK11. stm.sciencemag.org/content/1…
Congrats to two of the most thoughtful, honest, and courageous investors out there. Can’t wait to see what you do!
We’re excited to announce the launch of Vensana Capital and the close of our first fund at $225M — more here: businesswire.com/news/home/5…
Immensely proud of our full team from birth to today--was a thrilling and rewarding journey! Now, a happy and productive new home within @Ligand_LGND @timothyspringer @aaronmring @AashishManglik ligand.com/news-events/press…
Ken Lin retweeted
Let’s play a little game.
Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after.
Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?
My good friend, adding to his long list of successes. It’s so deeply impressive to see someone repeatedly be so intimately involved with creating amazing things from mere seeds. Congratulations, buddy!
Proud to share news of the acquisition of @VertiFlexInc by Boston Scientific for $465M plus earn outs today. Our investments can become very personal—none more so than VertiFlex for me. 1/5
prnewswire.com/news-releases…
Yup, that’s my girl, my partner, and love of my life these past 20+ years. I’m immensely proud!
Our @kiwico_inc community of young innovators and their grownup assistants continue to inspire us in every way. @lagorio shares our journey on @Inc. inc.com/christine-lagorio-ch…
Very happy for more of the world to know about @timothyspringer, the ideal of scientist/entrepreneur, prince, visionary, creator!
bloomberg.com/news/articles/…
Ken Lin retweeted
A Harvard professor just made $400 million in biotech's biggest IPO of the year, @rcurtisspalding reports: bloomberg.com/news/articles/…
Ken Lin retweeted
My dad just won the #Nobel prize for putting the red thingy into the blue thingy so it hooks on to the yellow thingy! #NobelPrize #phagedisplay #chemistry
2018 #NobelPrize laureate George Smith developed a method known as phage display, where a bacteriophage – a virus that infects bacteria – can be used to evolve new proteins.
Ken Lin retweeted
BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the #NobelPrize in Chemistry 2018 with one half to Frances H. Arnold and the other half jointly to George P. Smith and Sir Gregory P. Winter.





















